Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis

Cardiovascular Research

Volumn 75, Issue 4, 2007, Pages 803-812

  Sanz González, Silvia M ^a   Barquín, Leire ^b   García Cao, Isabel ^c   Roque, Mercè ^b   González, José M ^a   Fuster, José J ^a   Castells, M Teresa ^d   Flores, Juana M ^e   Serrano, Manuel ^c   Andrés, Vicente ^a  

^a INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d UNIVERSITY OF MURCIA   (Spain)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Atherosclerosis; Genetically modified mice; p53; Restenosis

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ENDOTHELIUM INJURY; FEMALE; FEMORAL ARTERY; GENE DOSAGE; GENE FUNCTION; HEART MUSCLE CELL; HETEROZYGOSITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RESTENOSIS; SMOOTH MUSCLE FIBER; TRANSGENE; TUMOR SUPPRESSOR GENE;

ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CELLS, CULTURED; DIET, ATHEROGENIC; FEMORAL ARTERY; GENE DOSAGE; GENE EXPRESSION; GENES, P53; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, ANIMAL; MYOCYTES, SMOOTH MUSCLE; TUNICA INTIMA;

EID: 34547768752     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.05.002     Document Type: Article

References (40)

1. Libby P., and Tanaka H. The molecular basis of restenosis. Prog Cardiovasc Dis 40 (1997) 97-106
2. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
3. Greaves D.R., and Channon K.M. Inflammation and immune responses in atherosclerosis. Trends Immunol 23 (2002) 535-541
4. Binder C.J., Chang M.K., Shaw P.X., Miller Y.I., Hartvigsen K., Dewan A., et al. Innate and acquired immunity in atherogenesis. Nat Med 8 (2002) 1218-1226
5. Sartore S., Chiavegato A., Faggin E., Franch R., Puato M., Ausoni S., et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res 89 (2001) 1111-1121
6. Dzau V.J., Braun-Dullaeus R.C., and Sedding D.G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8 (2002) 1249-1256
7. Andrés V. Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential. Cardiovasc Res 63 (2004) 11-21
8. Walsh K., Smith R.C., and Kim H.S. Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. Circ Res 87 (2000) 184-188
9. Fuster J.J., Sanz-González S.M., Moll U.M., and Andrés V. Classical and novel roles of p53: Prospects for anticancer therapy. Trends Mol Med 13 (2007) 192-199
10. Scott S., O'Sullivan M., Hafizi S., Shapiro L.M., and Bennett M.R. Human vascular smooth muscle cells from restenosis or in-stent stenosis sites demonstrate enhanced responses to p53: implications for brachytherapy and drug treatment for restenosis. Circ Res 90 (2002) 398-404
11. Speir E., Modali R., Huang E.S., Leon M.B., Shawl F., Finkel T., et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265 (1994) 391-394
12. Zhou Y.F., Leon M.B., Waclawiw M.A., Popma J.J., Yu Z.X., Finkel T., et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 335 (1996) 624-630
13. Iacopetta B., Wysocki S., Norman P., and House A. The p53 tumor suppressor gene is overexpressed but not mutated in human atherosclerotic tissue. Int J Oncol 7 (1995) 399-402
14. Ihling C., Menzel G., Wellens E., Monting J.S., Schaefer H.E., and Zeiher A.M. Topographical association between the cyclin-dependent kinases inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscler Thromb Vasc Biol 17 (1997) 2218-2224
15. Ihling C., Haendeler J., Menzel G., Hess R.D., Fraedrich G., Schaefer H.E., et al. Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions. J Pathol 185 (1998) 303-312
16. Guevara N.V., Kim H.S., Antonova E.I., and Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med 5 (1999) 335-339
17. *3-Leiden transgenic mice. Circ Res 88 (2001) 780-786
18. Merched A.J., Williams E., and Chan L. Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodeling. Arterioscler Thromb Vasc Biol 23 (2003) 1608-1614
19. Mercer J., Figg N., Stoneman V., Braganza D., and Bennett M.R. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ Res 96 (2005) 667-674
20. Mayr U., Mayr M., Li C., Wernig F., Dietrich H., Hu Y., et al. Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice. Circ Res 90 (2002) 197-204
21. Moroi M., Izumida T., Morita T., Tatebe J., Ishii C., Imai T., et al. Effect of p53 deficiency on external vascular cuff-induced neointima formation. Circ J 67 (2003) 149-153
22. Sata M., Tanaka K., Ishizaka N., Hirata Y., and Nagai R. Absence of p53 leads to accelerated neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 23 (2003) 1548-1552
23. Matsushita H., Morishita R., Aoki M., Tomita N., Taniyama Y., Nakagami H., et al. Transfection of antisense p53 tumor suppressor gene oligodeoxynucleotides into rat carotid artery results in abnormal growth of vascular smooth muscle cells. Circulation 101 (2000) 1447-1452
24. Yonemitsu Y., Kaneda Y., Tanaka S., Nakashima Y., Komori K., Sugimachi K., et al. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ Res 82 (1998) 147-156
25. Scheinman M., Ascher E., Levi G.S., Hingorani A., Shirazian D., and Seth P. p53 gene transfer to the injured rat carotid artery decreases neointimal formation. J Vasc Surg 29 (1999) 360-369
26. Wan S., George S.J., Nicklin S.A., Yim A.P., and Baker A.H. Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts. Molec Ther 9 (2004) 689-698
27. George S.J., Angelini G.D., Capogrossi M.C., and Baker A.H. Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosis. Gene Ther 8 (2001) 668-676
28. von der Thüsen J.H., van Vlijmen B.J., Hoeben R.C., Kockx M.M., Havekes L.M., van Berkel T.J., et al. Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53. Circulation 105 (2002) 2064-2070
29. García-Cao I., García-Cao M., Martín-Caballero J., Criado L.M., Klatt P., Flores J.M., et al. "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J 21 (2002) 6225-6235
30. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 415 (2002) 45-53
31. Maier B., Gluba W., Bernier B., Turner T., Mohammad K., Guise T., et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev 18 (2004) 306-319
32. Meir K.S., and Leitersdorf E. Atherosclerosis in the apolipoprotein E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 24 (2004) 1006-1014
33. Díez-Juan A., and Andrés V. The growth suppressor p27Kip1 protects against diet-induced atherosclerosis. Faseb J 15 (2001) 1989-1995
34. Roqué M., Fallon J.T., Badimon J.J., Zhang W.X., Taubman M.B., and Reis E.D. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol 20 (2000) 335-342
35. Ray J.L., Leach R., Herbert J.M., and Benson M. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci 23 (2001) 185-188
36. Poch E., Carbonell P., Franco S., Diez-Juan A., Blasco M.A., and Andres V. Short telomeres protect from diet-induced atherosclerosis in apolipoprotein E-null mice. Faseb J 18 (2004) 418-420
37. Scheinman M., Ascher E., Kallakuri S., Hingorani A., Gade P., Sherman M., et al. p53 gene transfer to the injured rat carotid artery promotes apoptosis. Surgery 126 (1999) 863-868
38. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8 (2002) 403-409
39. Poyurovsky M.V., and Prives C. Unleashing the power of p53: lessons from mice and men. Genes Dev 20 (2006) 125-131
40. Ringshausen I., O'Shea C.C., Finch A.J., Swigart L.B., and Evan G.I. Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo. Cancer Cell 10 (2006) 501-514